Literature DB >> 11744061

Apo-cytochrome b5 as an indicator of changes in heme accessability: preliminary studies with cytochrome P450 3A4.

A A Gilep1, O L Guryev, S A Usanov, R W Estabrook.   

Abstract

Cytochrome P450s (P450 or CYP) are the largest family of hemeproteins yet characterized. X-ray crystallographic studies have shown that the heme of the P450 hemeproteins is buried in the interior of the protein molecule. Unexplored are answers to questions concerning the role of heme in the folding of newly synthesized apo-P450s and the factors that influence changes in heme accessibility following modification of the pattern of folding of the holo-P450s. We have carried out the present studies to measure changes in heme accessibility in P450s. This is an initial step to determining whether heme-binding confers structural and functional integrity and stability to a P450 molecule. Recently, we have shown that apo-high molecular weight cytochrome b5 (apo-HMWb5) is an efficient acceptor of heme when added to a preparation of purified recombinant CYP3A4. In the present work we have studied heme binding by apo-HMWb5 when mixed with a number of different hemeproteins (myoglobin, hemoglobin, catalase, CYP4A1, CYP101, and CYP3A4). These hemeproteins differ in the location of the heme (i.e., surface or internal) allowing one to study changes in structure as measured by the process of heme transfer from one protein to another. It was found that heme transfer to apo-HMWb5 occurs relatively rapidly from hemeproteins where the heme is located at or near the surface or when the hemeprotein is denatured. In contrast, heme transfer from P450s to apo-HMWb5 occurs only following modification of the P450 structure with chaotropic agents. An exception is CYP3A4 where a measurable amount of heme is transferred to apo-HMWb5 in the absence of denaturing agents. The preliminary results described here employs apo-HMWb5 as an indicator for assessing changes in heme-availability of P450s as the protein-folding of the molecule is altered.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744061     DOI: 10.1016/s0162-0134(01)00333-6

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  4 in total

1.  Isatin-induced increase in the affinity of human ferrochelatase and adrenodoxin reductase interaction.

Authors:  Pavel Ershov; Yuri Mezentsev; Andrey Gilep; Sergey Usanov; Olga Buneeva; Alexei Medvedev; Alexis Ivanov
Journal:  Protein Sci       Date:  2017-10-09       Impact factor: 6.725

2.  Cross-linking mass spectrometry and mutagenesis confirm the functional importance of surface interactions between CYP3A4 and holo/apo cytochrome b(5).

Authors:  Chunsheng Zhao; Qiuxia Gao; Arthur G Roberts; Scott A Shaffer; Catalin E Doneanu; Song Xue; David R Goodlett; Sidney D Nelson; William M Atkins
Journal:  Biochemistry       Date:  2012-11-14       Impact factor: 3.162

3.  Mechanism of the Affinity-Enhancing Effect of Isatin on Human Ferrochelatase and Adrenodoxin Reductase Complex Formation: Implication for Protein Interactome Regulation.

Authors:  Pavel V Ershov; Alexander V Veselovsky; Yuri V Mezentsev; Evgeniy O Yablokov; Leonid A Kaluzhskiy; Anastasiya M Tumilovich; Anton A Kavaleuski; Andrei A Gilep; Taisiya V Moskovkina; Alexei E Medvedev; Alexis S Ivanov
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

4.  Cytochrome b5 plays a dual role in the reaction cycle of cytochrome P450 3A4 during oxidation of the anticancer drug ellipticine.

Authors:  Marie Stiborová; Radek Indra; Eva Frei; Kateřina Kopečková; Heinz H Schmeiser; Tomáš Eckschlager; Vojtěch Adam; Zbyněk Heger; Volker M Arlt; Václav Martínek
Journal:  Monatsh Chem       Date:  2017-07-04       Impact factor: 1.451

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.